Post-COVID Neurological Syndrome (PCNS) has emerged as a highly prevalent and disabling condition affecting millions globally in the aftermath of SARS CoV 2 infection. It is now clear that PCNS is not an enigmatic or rare disorder, but a measurable clinical entity driven by chronic low grade neuroinflammation disrupting key neural circuits. Despite its growing burden, PCNS remains largely overlooked in national and global research agendas, policy frameworks, and clinical care pathways. This lack of recognition perpetuates diagnostic delays, fragmented care, and patient suffering, especially in vulnerable and underserved populations. As we reach a critical juncture in the post-pandemic era, there is an urgent need to reframe PCNS within a systems neuroscience and public health paradigm. This chapter calls for coordinated research, data sharing, and community driven action to address PCNS comprehensively. It aligns with the World Health Organization’s Intersectoral Global Action Plan (IGAP) and the Sustainable Development Goals, especially SDG 3: Good Health and Wellbeing. We conclude that addressing PCNS is not just about recovery. It is about equity, innovation, and building the future of person centered, precision brain health.